DVA - DaVita Inc Stock Analysis

DaVita Inc (DVA) is a publicly traded company listed on the . It operates in the industry, part of the broader sector. The company has a market capitalization of 11.49B, generates annual revenue of 14.01B, and reports net income of 822.48M. As of the latest data, the stock is trading at 180.06 USD.

From a valuation and risk perspective, the stock presents the following profile: The stock appears reasonably valued, potentially indicating balanced risk and return. The PEG ratio is below 1, which may indicate the stock is undervalued relative to its growth potential. The company has very low leverage, which may indicate conservative financial management or underutilization of debt. This stock does not currently pay a dividend. This stock tends to be less volatile than the overall market, often preferred by conservative investors.

Analyst recommendation stands at Hold (3.54), indicating current market sentiment. Institutional ownership is reported at 93.61%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 33.86%, trading within a 52-week range of 101.00 - 247.49.

DVA - DaVita Inc

180.06
Analyst Consensus
Hold 3.54
DVA – Analyst Rating Summary
Analyst Pie Chart
  • Strong Buy: 1
  • Buy: 6
  • Hold: 5
  • Sell: 1
  • Strong Sell: 0
  • Total Analysts:  13

Last update: 2026-09-09 04:48:01
Index: S&P 500 P/E: 15.19 EPS (ttm): 11.86 Insider Own: 2.07% Shs Outstand: 63.80M Perf Week: 2.30%
Market Cap: 11.49B Forward P/E: 10.56 EPS next Y: 17.06 Insider Trans: -54.43% Shs Float: 62.48M Perf Month: -2.02%
Income(ttm): 822.48M PEG: 0.47 EPS next Q: 3.58 Inst Own: 93.61% Short Float: 6.41% Perf Quarter: -6.26%
Revenue(ttm): 14.01B P/S: 0.82 EPS this Y: 37.71% Inst Trans: -3.66% Short Ratio: 4.85 Perf Half Y: 18.03%
Book/sh: -13.03 P/B: - EPS next Y: 14.90% ROA: 4.67% Short Interest: 4.00M Perf Year: 33.86%
Cash/sh: 12.10 P/C: 14.89 EPS next 5Y: 22.62% ROE: 635.30% 52W Range: 101.00 - 247.49 Perf YTD: 58.49%
Dividend Est.: - P/FCF: 7.14 EPS past 3/5Y: 18.56% 8.29% ROIC: 6.81% 52W High: 247.49 -27.25% Beta: 0.79
Dividend TTM: - Quick Ratio: 1.41 Sales past 3/5Y: 5.53% 3.39% Gross Margin: 27.29% 52W Low: 101.00 78.28% Perf 5Y: 39.51%
Dividend Ex-Date: - Current Ratio: 1.47 EPS Y/Y TTM: 16.30% Oper. Margin: 14.93% RSI (14): 39.98 Volatility: 2.25% 2.51%
Employees: 78000 Debt/Eq: - Sales Y/Y TTM: 6.45% Profit Margin: 5.87% Recom: 2.20 Target Price: 227.33
Option/Short: Yes / Yes LT Debt/Eq: - EPS Q/Q: 55.84% Payout: 0.00% Rel Volume: 0.75 Prev Close: 183.99
Sales Surprise: 1.65% EPS Surprise: 3.55% Sales Q/Q: 5.17% Earnings: Aug 04 AMC Avg Volume: 825.46K Price: 180.06
SMA20: 0.84% SMA50: -13.24% SMA200: 9.53% Undervalued: 26.25%
Volume: 621,338 Change: -2.14%
Graham's revised valuation formula
Discounted cash flow (DCF) model
Margin of safety

About DaVita Inc

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.

Copyright © 2024 - 2026 www.stocks-expert.com All Rights Reserved.